Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation

Genes Chromosomes and Cancer

Volumn 40, Issue 3, 2004, Pages 190-203

  Kittiniyom, Kanokwan ^a,b   Mastronardi, Michelle ^a   Roemer, Martha ^a   Wells, Wendy A ^c   Greenberg, E Robert ^d   Titus Ernstoff, Linda ^d   Newsham, Irene F ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c DARTMOUTH COLLEGE   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DAL 1/4.1B PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CHROMOSOME 18P; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; INTRON; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FAMILY; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; ALANINE; ALLELES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME MAPPING; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; GENOMIC IMPRINTING; HUMANS; INTRONS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; SERINE; TUMOR SUPPRESSOR PROTEINS;

EID: 2542599976     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20034     Document Type: Article

References (40)

1. Baklouti F, Huang SC, Vulliamy TJ, Delaunay J, Benz EJ, Jr. 1997. Organization of the human protein 4.1 genomic locus: new insights into the tissue-specific alternative splicing of the pre-mRNA. Genomics 39:289-302.
2. Byun DS, Cho K, Ryu BK, Lee MG, Park JI, Chae KS, Kim HJ, Chi SG. 2003. Frequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinoma. Int J Cancer 104:318-327.
3. Charboneau AL, Singh V, Yu T, Newsham IF. 2002. Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells. Int J Cancer 100:181-188.
4. Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspal M, Jindal H, Liu SC, Low PS, Rouleau GA, Mohandas N, Chasis JA, Conboy JG, Gascard P, Takakuwa Y, Huang SC, Benz EJ, Jr., Bretscher A, Fehon RG, Gusella JF, Ramesh V, Solomon F, Marchesi VT, Tsukita S, Tsukita S, Hoover KB, 1998. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 23:281-282.
5. Cody JD, Pierce JF, Brkanac Z, Plaetke R, Ghidoni PD, Kaye CI, Leach RJ. 1997. Preferential loss of the paternal alleles in the 18q-syndrome. Am J Med Genet 69:280-286.
6. Correas I, Perez-Ferreiro CM, Lallena MJ, Luque CM. 2001. Nuclear and cytoplasmic localization signals in protein 4.1R. Cell Mol Biol Lett 6:195.
7. De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bono P, Grammatico B, Grammatico P, Radice P, Bigozzi U, Monrali E, Papi L. 1996. Analysis of the neurofibromarosis type 2 gene in different human rumors of neuroectodermal origin. Hum Genet 97:638-641.
8. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R. 1992. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841-846.
9. Gascard P, Lee G, Coulombel L, Auffray I, Lum M, Parra M, Conboy JG, Mohandas N, Chasis JA. 1998. Characterization of multiple isoforms of protein 4.1R expressed during erythroid terminal differentiation. Blood 92:4404-4414.
10. Gershon ES, Badner JA, Detera-Wadleigh SD, Ferraro TN, Berrettini WH. 1996. Maternal inheritance and chromosome 18 allele sharing in unilineal bipolar illness pedigrees. Am J Med Genet 67:202-207.
11. Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF. 2000. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 9:1495-1500.
12. Gutmann DH, Hirbe AC, Huang R, Haipek CA. 2001. The protein 4.1 tumor suppressor, dal-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol Dis 8:266-278.
13. Heinrich B, Hartmann C, Stemmer-Rachamimov AO, Louis DN, MacCollin M. 2003. Multiple meningiomas: investigating the molecular basis of sporadic and familial forms. Int J Cancer 103:483-488.
14. Hoover KB, Bryant PJ. 2000. The genetics of the protein 4.1 family: organizers of the membrane and cytoskeleton. Curr Opin Cell Biol 12:229-234.
15. Huang JP, Tang CJ, Kou GH, Marchesi VT, Benz EJ Jr, Tang TK. 1993. Genomic structure of the locus encoding protein 4.1. Structural basis for complex combinational patterns of tissue-specific alternative RNA splicing. J Biol Chem 268:3758-3766.
16. Issa JP, Vertino PM, Boehm CD, Newsham IF, Baylin SB. 1996. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA 93:11757-11762.
17. Kimura Y, Koga H, Araki N, Mugita N, Fujita N, Takeshima H, Nishi T, Yamashima T, Saido TC, Yamasaki T, Moritake K, Saya H, Nakao M. 1998. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas. Nat Med 4:915-922.
18. Kimura Y, Saya H, Nakao M. 2000. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas. Neuropathology 20:153-160.
19. Kittiniyom K, Gorse KM, Dalbegue F, Lichy JH, Taubenberger JK, Newsham IF. 2001. Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression. Breast Cancer Res 3:192-198.
20. Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M. 2001. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci USA 98:11563-11568.
21. Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJ, Kley N. 1994. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022-1029.
22. Luque CM, Perez-Ferreiro CM, Perez-Gonzalez A, Englmeier L, Koffa MD, Correas I. 2003. An alternative domain containing a leucine-rich sequence regulates nuclear cytoplasmic localization of protein 4.1R. J Biol Chem 278:2686-2691.
23. Merel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X. 1995. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer 13:211-216.
24. Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O. 1999. Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 6:63-70.
25. Ohara R, Yamakawa H, Nakayama M, Ohara O. 2000. Type II brain 4.1 (4.1B/KIAA0987), a member of the protein 4.1 family, is localized to neuronal paranodes. Brain Res Mol Brain Res 85:41-52.
26. Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U. 1995. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95:347-351.
27. Parra M, Gascard P, Walensky LD, Gimm JA, Blackshaw S, Chan N, Takakuwa Y, Berger T, Lee G, Chasis JA, Snyder SH, Mohandas N, Conboy JG. 2000. Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain. J Biol Chem 275:3247-3255.
28. Perry A, Cai DX, Scheithauer BW, Swanson PE, Lohse CM, Newsham IF, Weaver A, Gutmann DH. 2000. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol 59:872-879.
29. Peters LL, Weier HU, Walensky LD, Snyder SH, Parra M, Mohandas N, Conboy JG. 1998. Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human. Genomics 54:348-350.
30. Schmucker B, Tang Y, Kressel M. 1999. Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules. Hum Mol Genet 8:1561-1570.
31. Slavc I, MacCollin MM, Dunn M, Jones S, Sutton L, Gusella JF, Biegel JA. 1995. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 64:243-247.
32. Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, Burwick JA, Pinney D, Beauchamp R, Jacoby LB, Gusella JF, Ramesh V, Louis DN. 1997. Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol 151:1649-1654.
33. Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C, Clark CD, McInnis MG, Simpson SG, Breschel TS, et al. 1995. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet 57:1384-1394.
34. Stokowski RP, Cox DR. 2000. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations. Am J Hum Genet 66:873-891.
35. Tran Y, Benbatoul K, Gorse K, Rempel S, Futreal A, Green M, Newsham I. 1998. Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. Oncogene 17:3499-3505.
36. Tran YK, Bogler O, Gorse KM, Wieland I, Green MR, Newsham IF. 1999. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res 59:35-43.
37. Woodcock DM, Linsenmeyer ME, Doherty JP, Warren WD. 1999. DNA methylation in the promoter region of the p16 (CDKN2/ MTS-1/INK4A) gene in human breast tumours. Br J Cancer 79:251-256.
38. Yamakawa H, Ohara O. 2000. Comparison of mRNA and protein levels of four members of the protein 4.1 family: the type II brain 4.1/4.1B/KIAA0987 is the most predominant member of the protein 4.1 family in rat brain. Gene 248:137-145.
39. Yamakawa H, Ohara R, Nakajima D, Nakayama M, Ohara O. 1999. Molecular characterization of a new member of the protein 4.1 family (brain 4.1) in rat brain. Brain Res Mol Brain Res 70:197-209.
40. Yu T, Robb VA, Singh V, Gutmann DH, Newsham IF. 2002. The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumor suppressor interacts with 14-3-3 proteins. Biochem J 365:783-789.